Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression

Michael J. Willhauck, Bibi Rana Sharif Samani, Franz Josef Gildehaus, Ingo Wolf, Reingard Senekowitsch-Schmidtke, Hans Jürgen Stark, Burkhard Göke, John C. Morris, Christine Spitzweg

Research output: Contribution to journalArticle

42 Scopus citations

Fingerprint Dive into the research topics of 'Application of <sup>188</sup>rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds